Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.

CONCLUSION: In this study evaluating the perspectives of patients and physicians on AIT, the majority of patients were satisfied with the efficacy and safety of AIT, but not its cost. AIT should be recommended for AR and allergic patients.
PMID: 31016906 [PubMed - in process]

Source: Yonsei Medical Journal - April 25, 2019 Category: Universities & Medical Training Authors: Shin YS, Jung JW, Park JW, Choi JH, Kwon JW, Lee S, Kim JH, Lee SM, Ahn YM, Han MY, Allergen and Immunotherapy Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI) Tags: Yonsei Med J Source Type: research